Stock screenerAll disclosures →
EDGAR →
KYTX
Conviction 32HealthcareScan · Mon, Aug 10, 2026KYTX$7.90-0.75%
ResistanceSupportVol 14Vol MA14 833.29K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.90
Change-0.75%
Gap+0.13%
Rel volume2.36×
Avg volume959.92K
Avg $ vol7.28M
SMA 207.56
SMA 508.05
SMA 2008.29
Price vs 50-1.81%
Price vs 200-4.72%
MA stackbearish
50/200 crossdeath · 9d
Supertrenddown · 8.87
RSI (14)51
MACD hist0.08
MACD crossbull · 4d
Stoch %K / %D79 / 77
ADX (14)14
+DI / −DI20 / 17
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.01%
ADR %5.60%
52w high11.25
52w low3.02
From 52w high-29.78%
Above 52w low+161.59%
New 52w highNo
SqueezeOn · 3d
Bollinger width13.30%
%B0.84
Donchian pos79.31%
Donchian high8.14
Donchian low6.98
AVWAP (52w high)8.78
vs AVWAP high-10.00%
AVWAP (52w low)8.30
vs AVWAP low-4.81%
OBV trendDown
Chaikin MF (20)-0.11
Today vs 20d2.36×
Avg vol (14d)833.29K
Avg vol (20d)959.92K
Avg $ vol (20d)7.28M
Market cap480.28M
RS 3m (vs SPY)-20.11%
RS 6m (vs SPY)-4.62%
RS line new highNo
Trend template3/8
Technical rank36.7
1 week+5.19%
1 month-6.89%
3 months-15.51%
6 months-0.38%
1 year+138.67%
YTD-9.92%
P/E-2.98
P/B2.46
P/S—
P/FCF-3.12
EPS-3.64
Div yield—
ROE-82.48%
ROA-62.76%
Debt/Eq—
Current8.15
EV/EBITDA-2.67
Gross margin—
Net margin—
Rev growth—
EPS growth-26.54%
Price target30.00
Target upside279.75%
Analyst ratingBuy
Institutional75.02%
Ent. value448.09M
Revenue—
Net income-39.73M
Gross profit—
Free cash flow-153.72M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out60.8M
Employees129
ListedThu, Feb 8, 2024
Free float35.7M
Float %59.1%
Short interest7.85M
Days to cover6.0d
Short volume39.2%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.66 vs −$0.75
Last surprise+12.0% beat
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank36.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.77
Support7.04
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KYTX
No recent disclosed trades by Congress in KYTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KYTX · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
CLARK IAN T Director · Stock Option (right to buy) · 2026-05-27 | Grant | 20.58K | $0 | 2026-05-27 | 2026-05-29 |
SEIDENBERG BETH C Director · Stock Option (right to buy) · 2026-05-27 | Grant | 20.58K | $0 | 2026-05-27 | 2026-05-29 |
Cohen Fred E Director · Common Stock · 2026-05-27 | Grant | 5.09K | $0 | 2026-05-27 | 2026-05-29 |
Shaw Christi Executive Chairperson · Common Stock · 2026-05-27 | Tax | 4.19K | $36K | 2026-05-27 | 2026-05-29 |
Aktar Mert Director · Common Stock · 2026-05-27 | Grant | 5.09K | $0 | 2026-05-27 | 2026-05-29 |
Cohen Fred E Director · Common Stock · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
SEIDENBERG BETH C Director · Common Stock · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
Cohen Fred E Director · Stock Option (right to buy) · 2026-05-27 | Grant | 20.58K | $0 | 2026-05-27 | 2026-05-29 |
Aktar Mert Director · Stock Option (right to buy) · 2026-05-27 | Grant | 20.58K | $0 | 2026-05-27 | 2026-05-29 |
CLARK IAN T Director · Common Stock · 2026-05-27 | Grant | 5.09K | $0 | 2026-05-27 | 2026-05-29 |
SEC filings
EDGAR filings in KYTX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.